Product Information
LORAZEPAM 2 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0706 per EA under NDC 00904600961. Its NADAC has been published 482 times since Feb 8, 2017.
FDA first approved this application on Jul 30, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904600961
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
4/22/2026
Active Ingredients
LORAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA078203FDA Approved
7/30/2007
TE Code
AB
On Market Since
10/9/2009
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 2 MG TABLET has been published 482 times since Feb 8, 2017, and over the history we have for it it has risen 68.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0706 per EA |
|---|---|
| All-time high | $0.0866 (Jan 10, 2024) |
| All-time low | $0.0399 (Jan 17, 2018) |
| 52-week high | $0.0764 |
| 52-week low | $0.0695 |
| Median price | $0.0678 |
| Average price | $0.0644 |
| Largest weekly change | -30.9% (Nov 20, 2024) |
| Weeks tracked | 482 |
| Tracking since | Feb 8, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
+1.6%
1Y
-7.0%
3Y
+9.2%
5Y
-10.4%
All
+68.1%
Last surveyed Apr 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 40% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LORAZEPAM 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 2 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0706 per EA (NDC 00904600961), effective Apr 29, 2026.
How has the price of LORAZEPAM 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 2 MG TABLET has risen 68.1%. It has been tracked across 482 weekly CMS publications since Feb 8, 2017.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 2 MG TABLET?
Since Feb 8, 2017, the NADAC for LORAZEPAM 2 MG TABLET has ranged from a low of $0.0399 (Jan 17, 2018) to a high of $0.0866 (Jan 10, 2024), with a median of $0.0678 per EA.
Are there cheaper alternatives to LORAZEPAM 2 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LORAZEPAM 2 MG TABLET, is $0.0424 per EA — about 40% below LORAZEPAM 2 MG TABLET.
Who manufactures LORAZEPAM 2 MG TABLET?
LORAZEPAM 2 MG TABLET (NDC 00904600961) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.